Matthias Hofer has been appointed as Managing Partner of Stonehaven Consulting AG, taking over leadership of the company from George Gunn.
Matthias was formerly a Partner and has over 15 years of experience in the animal health sector. He served on the executive committees of two major animal health companies prior to joining Stonehaven Consulting.
George Gunn, founder of Stonehaven Consulting and former CEO, said: “Matthias is a business leader with broad international experience and particular strengths in sales, strategy and execution. It was a natural progression for him to become Managing Partner of Stonehaven Consulting as he’s been heavily involved in running the company since its inception.”
Matthias Hofer added: “I’m delighted to have this opportunity to lead Stonehaven Consulting as we move into the new decade. We can expect to see many exciting developments in the life science sector over the next 10 years and Stonehaven Consulting will be here to help business make the most of the opportunities.”
Between 2009 and 2013 Matthias led the global Aqua Health business at Novartis Animal Health (NAH). He was later the Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee.
Stonehaven Consulting helps innovative life sciences companies strengthen their businesses at various stages of development.
ends
Notes to editor:
Swiss based Stonehaven Consulting was founded in 2015 and is a specialist life sciences consulting company. Focused on animal health and with a unique business model, it has a small team of highly qualified and experienced individuals who use their know-how and network to help companies across the globe set and exceed their strategic goals. Stonehaven serves innovative life sciences companies at various phases of development.
Its consultants are based in Europe and in North America, but also carry out assignments in Asia and in Latin America. Stonehaven has a unique global perspective and is constantly breaking barriers and extending partnerships to innovative life sciences companies.
For more information contact Mike Keeler or Alistair Moses at Garnett Keeler PR on +44 (0)20 8647 4467 or mike.keeler@garnettkeeler.com / alistair.moses@garnettkeeler.com
STO/061/19
